[1]刘子扬,陈有信.息肉状脉络膜血管病变的危险因素分析[J].眼科新进展,2018,38(6):538-541.[doi:10.13389/j.cnki.rao.2018.0125]
　LIU Zi-Yang,CHEN You-Xin.Ocular risk factors for polypoidal choroidal vasculopathy[J].Recent Advances in Ophthalmology,2018,38(6):538-541.[doi:10.13389/j.cnki.rao.2018.0125]
点击复制

息肉状脉络膜血管病变的危险因素分析/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
38卷
期数:
2018年6期
页码:
538-541
栏目:
应用研究
出版日期:
2018-06-05

文章信息/Info

Title:
Ocular risk factors for polypoidal choroidal vasculopathy
作者:
刘子扬; 陈有信
100730　北京市，中国医学科学院，北京协和医学院，北京协和医院眼科
Author(s):
LIU Zi-Yang; CHEN You-Xin
Ophthalmology，Peking Union Medical College Hospital，Peking Union Medical College，Chinese Academy of Medical Sciences，Beijing 100730，China
关键词:
息肉状脉络膜血管病变; 危险因素; 高血压; 吸烟; 眼轴长度
Keywords:
polypoidal choroidal vasculopathy;  risk factors;  hypertension;  smoking;  axial length
分类号:
R773.4
DOI:
10.13389/j.cnki.rao.2018.0125
文献标志码:
A
摘要:
目的　评估和分析息肉状脉络膜血管病变（polypoidal choroidal vasculopathy，PCV）发病的潜在危险因素以及PCV亚型间潜在危险因素的差异。方法　回顾性病例对照研究。收集2016年7月至2018年1月于我院就诊的PCV患者64例（64眼）作为PCV组，并根据脉络膜厚度分为厚脉络膜型PCV（厚PCV组）和薄脉络膜型PCV（薄PCV组）两型。收集2016年1月至2017年12月收入我院眼科病房行老年性白内障手术的患者42例（42眼）作为对照组。收集所有研究对象的详细病史，包括年龄、性别、最佳矫正视力、血压、血脂、心血管疾病、吸烟史、饮酒史和眼轴长度。单因素分析和Logistic回归分析与对照组相比，PCV组以及PCV亚组（厚PCV组和薄PCV组）潜在的危险因素。结果　单因素分析结果显示，PCV组较对照组具有更大的年龄（P=0.046）、更高的高血压比例（P=0.021）、吸烟者比例更大（P=0.036）、眼轴长度更短（P=0.005），而血脂异常、心血管疾病和饮酒史在两组间差异均无统计学意义（均为P>0.05），Logistic回归结果显示，两组年龄、高血压、吸烟史和眼轴长度差异仍具有统计学意义（均为P<0.05）。亚组间Logistic回归结果显示，厚PCV组与对照组间高血压、吸烟史和眼轴长度差异均具有统计学意义（均为P<0.05），薄PCV组与对照组间年龄、吸烟史和眼轴长度差异均有统计学意义（均为P<0.05），厚PCV组与薄PCV组仅年龄和眼轴长度差异具有统计学意义（均为P<0.05）。结论　年龄、高血压、吸烟史和眼轴长度是PCV的危险因素。在PCV两种亚型中，厚脉络膜型PCV比薄脉络膜型PCV患者更年轻且具有更短的眼轴长度，但两种亚型患病的全身系统性危险因素是相似的。
Abstract:
Objective　To evaluate potential risk factors for polypoidal choroidal vasculopathy （PCV） and PCV subtypes.Methods　This was a retrospective case-control study.Totally 64 patients （64 eyes） of PCV(PCV group) in our hospital from July 2016 to January 2018 were enrolled and subgrouped into thick PCV and thin PCV.Additional 42 patients （42 eyes） who underwent cataract surgery in our hospital from January 2016 to December 2017 were collected as controls.Then the detailed history of all subjects were collected，including age，gender，best corrected visual acuity （BCVA），hypertension，dyslipidemia，cardiovascular diseases，ever-smoking history，alcohol consumption，and axial length.Univariate analysis and Logistic regression analysis was used to analyze the potential risk factors in patients from PCV group and PCV subgroups compared with controls.Results　Univariate analysis showed that PCV had an older age （P=0.046），a higher incidence of hypertension （P=0.021），a greater proportion of smokers （P=0.036），and a shorter axial length （P=0.005） than controls，while there was no statistical difference in dyslipidemia，cardiovascular diseases and alcohol consumption between the two groups （all P>0.05）.Logistic regression showed that age，hypertension，ever-smoking history，and axial length were still statistically significant （all P<0.05）.In addition，comparison between thick PCV patients and controls revealed a statistically significant difference in hypertension，ever-smoking history，and axial length （all P<0.05），and there was a statistically significant difference between age，ever-smoking history and axial length between the thin PCV group and control group （all P<0.05）.Thick PCV group and thin PCV group had statistically significant differences only in age and axial length （both P<0.05）.Conclusion　The potential risk factors for PCV includes age，hypertension，ever-smoking history，and axial length.In both PCV subtype groups，thick PCV patients are younger and have a shorter axial length than thin PCV patients，but systemic risk factors of thick PCV patients are similar to the thin PCV ones.

参考文献/References:

［1］　LIU Z Y,XIA S.YANG J Y,CHEN Y X.Correlation of 1-year vision outcomes with baseline factors in polypoidal choroidal vasculopathy patients after anti-VEGF treatment［J］.Rec Adv Ophthalmol,2018,38(5):440-443.
刘子扬，夏松，杨景元，陈有信.息肉状脉络膜血管病变抗血管内皮生长因子（VEGF）治疗后1年的视力预后与基线特征的相关性分析［J］.眼科新进展，2018,38(5):440-443.
［2］　GOMI F，TANO Y.Polypoidal choroidal vasculopathy and treatments［J］.Curr Opin Ophthalmol，2008，19（2）：208-212.
［3］　CACKETT P，YEO I，CHEUNG C M，VITHANA E N，WONG D，TAY W T，et al.Relationship of smoking and cardiovascular risk factors with polypoidal choroidal vasculopathy and age-related macular degeneration in Chinese persons［J］.Ophthalmology，2011，118（5）：846-852.
［4］　WOO S J，AHN J，MORRISON M A，AHN S Y，LEE J，KIM K W，et al.Analysis of genetic and environmental risk factors and their interactions in Korean patients with age-related macular degeneration［J］.PLoS One，2015，10 （7）：e0132771.
［5］　KIKUCHI M，NAKAMURA M，ISHIKAWA K，SUZUKI T，NISHIHARA H，YAMAKOSHI T，et al.Elevated C-reactive protein levels in patients with polypoidal choroidal vasculopathy and patients with neovascular age-related macular degeneration［J］.Ophthalmology，2007，114（9）：1722-1727.
［6］　SAKURADA Y，YONEYAMA S，IMASAWA M，IIJIMA H.Systemic risk factors associated with polypoidal choroidal vasculopathy and neovascular age-related macular degeneration［J］.Retina，2013，33（4）：841-845.
［7］　CHEUNG C M，LAUDE Y E O，TAN S P，FAN Q，MATHUR R.Systemic，ocular and genetic risk factors for age-related macular degeneration and polypoidal choroidal vasculopathy in singaporeans［J］.Sci Rep，2017，7：41386.
［8］　TANAKA K，MORI R，KAWAMURA A，NAKASHIZUKA H，WAK-ATSUKI Y，YUZAWA M.Comparison of OCT angiography and indocyanine green angiographic findings with subtypes of polypoidal choroidal vasculopathy［J］.Br J Ophthalmol，2017，101（1）：51-55.
［9］　YUZAWA M.Two subtypes of polypoidal choroidal vasculopathy：Idiopathic disease or age-related macular degeneration［J］.Invest Ophthalmol Vis Sci，2015，56（6）：3998.
［10］　COSCAS G，LUPIDI M，COSCAS F，BENJELLOUN F，ZERBIB J，DIRANI A，et al.Toward a specific classification of polypoidal choroidal vasculopathy：Idiopathic disease or subtype of age-related macular degeneration［J］.Invest Ophthalmol Vis Sci，2015，56（5）：3187-3195.
［11］　GUPTA P，TING D S W，THAKKU S G，WONG T Y，CHENG C Y，WONG E，et al.Detailed characterization of choroidal morphologic and vascular features in age-related macular degeneration and polypoidal choroidal vasculopathy［J］.Retina，2017，37（12）：2269-2280.
［12］　LEE WK，BAEK J，DANSINGANI K K，LEE J H，FREUND K B.Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal thickness［J］.Retina，2016，36（1）：73-82.
［13］　NAKANISHI H，YAMASHIRO K，YAMADA R，GOTOH N，HAYASHI H，NAKATA I，et al.Joint effect of cigarette smoking and CFH and LOC387715/HTRA1 polymorphisms on polypoidal choroidal vasculopathy［J］.Invest Ophthalmol Vis Sci，2010，51（12）：6183-6187.
［14］　LAUDE A，CACKETT P D，VITHANA E N，YEO I Y，WONG D.Polypoidal choroidal vasculopathy and neovascular age-related macular degeneration：same or different disease［J］? Prog Retin Eye Res，2010，29（1）：19-29.
［15］　BEATTY S，KOH H，PHIL M，HENSON D，BOULTON M.The role of oxidative stress in the pathogenesis of age-related macular degeneration［J］.Surv Ophthalmol，2000，45 （2）：115-134.
［16］　SOLBERG Y，ROSNER M，BELKIN M.The association between cigarette smoking and ocular diseases［J］.Surv Ophthalmol，1998，42（6）：535-547.
［17］　SUNER IJ，ESPINOSA-HEIDMANN D G，MARIN-CASTANO M E，HERNANDEZ E P，PEREIRA-SIMON S，COUSINS S W.Nicotine increases size and severity of experimental choroidal neovascularization［J］.Invest Ophthalmol Vis Sci，2004，45 （1）：311-317.
［18］　MENG Q，HUANG L，SUN Y，BAI Y，WANG B，YU W，et al.Effect of high-density lipoprotein metabolic pathway gene variations and risk factors on neovascular age-related macular degeneration and polypoidal choroidal vasculopathy in China［J］.PLoS One，2015，10（12）：e0143924.
［19］　UETA T，OBATA R，INOUE Y，TAKAHASHI H，YAMAGUCHI T，TAMAKI Y，et al.Background comparison of typical age-related macular degeneration and polypoidal choroidal vasculopathy in Japanese patients［J］.Ophthalmology，2009，116 （12）：2400-2406.
［20］　KABASAWA S，MORI K，HORIE-INOUE K，GEHLBACH P L，INOUE S，AWATA T，et al.Associations of cigarette smoking but not serum fatty acids with age-related macular degeneration in a Japanese population［J］.Ophthalmology，2011，118（6）：1082-1088.

相似文献/References:

[1]刘延东.息肉状脉络膜血管病变眼底影像检查特征[J].眼科新进展,2012,32(12):000.
[2]边领斋 刘巨平 魏瑞华 李筱荣 赵少贞 华宁 王铁成 李颖 任新军 梁娟 邹媛媛 赵小云 刘文洁.云南省高海拔农村多民族聚居区年龄相关性白内障危险因素调查[J].眼科新进展,2013,33(1):000.
[3]崔颖 郭海科 韩云飞 孟倩丽 张良 尹东明.2型糖尿病住院患者糖尿病视网膜病变患病率及危险因素分析[J].眼科新进展,2012,32(8):000.
[4]谭思敏 李瑞庄 黎宗汉 方林彬.原发性青光眼滤过术后发生恶性青光眼的危险因素分析[J].眼科新进展,2013,33(12):000.
[5]王宗华,李秋平,李耀宇,等. 极低出生体质量早产儿视网膜病变筛查及相关因素分析[J].眼科新进展,2014,34(4):361.[doi:10.13389/j.cnki.rao.2014.0098]
[6]吴京阳,刘磊,耿金,等.eGFR作为糖尿病视网膜病变预警因子的研究[J].眼科新进展,2014,34(8):740.[doi:10.13389/j.cnki.rao.2014.0203]
　WU Jing-Yang,LIU Lei,GENG Jin,et al.Study on estimated GFR as predictor of DR[J].Recent Advances in Ophthalmology,2014,34(6):740.[doi:10.13389/j.cnki.rao.2014.0203]
[7]金玮,杨安怀,邢怡桥,等.内眼手术及外伤术后迟发型脉络膜上腔出血的处理[J].眼科新进展,2014,34(12):1177.[doi:10.13389/j.cnki.rao.2014.0327]
　JIN Wei,YANG An-Huai,XING Yi-Qiao,et al.Management of delayed suprachoroidal hemorrhage after intraocular surgery and trauma[J].Recent Advances in Ophthalmology,2014,34(6):1177.[doi:10.13389/j.cnki.rao.2014.0327]
[8]王宗华,李秋平,白华,等. 早产儿视网膜病变自然消退和进展的影响因素研究[J].眼科新进展,2015,35(2):168.[doi:10.13389/j.cnki.rao.2015.0045]
　WANG Zong-Hua,LI Qiu-Ping,BAI Hua,et al. Influencing factors of spontaneous regression and progression of retinopathy of prematurity[J].Recent Advances in Ophthalmology,2015,35(6):168.[doi:10.13389/j.cnki.rao.2015.0045]
[9]闫瑾,王莉,杨扬. 近视的危险因素及流行病学研究进展[J].眼科新进展,2015,35(9):896.[doi:10.13389/j.cnki.rao.2015.0245]
　YAN Jin,WANG Li,YANG Yang. Recent advances in risk factors and epidemiology of myopia[J].Recent Advances in Ophthalmology,2015,35(6):896.[doi:10.13389/j.cnki.rao.2015.0245]
[10]刘子扬,叶俊杰.息肉状脉络膜血管病变并发玻璃体积血的机制研究[J].眼科新进展,2016,36(2):193.[doi:10.13389/j.cnki.rao.2016.0053]
　LIU Zi-Yang,YE Jun-Jie.Research on mechanism of polypoidal choroidal vasculopathy combined with vitreous hemorrhage[J].Recent Advances in Ophthalmology,2016,36(6):193.[doi:10.13389/j.cnki.rao.2016.0053]

备注/Memo

备注/Memo:
国家自然科学基金项目（编号：81670879）
更新日期/Last Update: 2018-07-10